National Osteoporosis Institute

The National Osteoporosis Institute (NOI) is a specialized clinical research and medical facility dedicated to the diagnosis, prevention, and treatment of osteoporosis and other metabolic bone disorders. Based in Lady Lake, Florida, the institute operates as a high-volume clinical trial site, collaborating with global pharmaceutical companies to conduct Phase 2 through Phase 4 studies. NOI has played a pivotal role in the clinical development and FDA approval of several landmark bone-health therapies, including bisphosphonates, SERMs, and monoclonal antibodies. Led by renowned expert Dr. Richard S. Bockman, the institute combines cutting-edge research with specialized patient care, utilizing advanced diagnostic technologies like high-resolution DXA scanning. The organization is a key contributor to the advancement of therapeutic standards in the field of endocrinology and bone metabolism.